EndoInSight

EndoInSight, a medical organization based in Memphis, Tennessee, was founded to mitigate the discomfort associated with colorectal cancer (CRC) screenings. The company focuses on providing clinicians with cost-effective CO2 colonoscopy techniques, which replace traditional air inflation methods to reduce patient bloating and discomfort post-procedure. Their core mission is to lower the societal impact of CRC by enhancing the patient experience during colonoscopies, making screenings more tolerable and accessible.

EndoInSight has garnered attention for its innovative approach to CRC screening, drawing interest from notable healthcare professionals and investors committed to advancing medical technologies. The organization has achieved significant milestones in improving patient comfort and compliance with CRC screenings. By addressing a critical pain point in the screening process, EndoInSight has made a meaningful impact on public health, potentially increasing early detection rates and saving lives through more effective CRC prevention strategies.